ALPPS一期术后未能行二期手术原因的临床分析

邓青松; 何明莲; 欧晏娇; 冯凯; 马宽生; 张雷达

doi:10.16016/j.2097-0927.202206085

您当前的位置：

首页 >

文章列表页 >

ALPPS一期术后未能行二期手术原因的临床分析

临床医学 | 更新时间：2026-01-09

- ALPPS一期术后未能行二期手术原因的临床分析
- Failure to perform second-stage operation after first one of associating liver partition and portal vein ligation for staged hepatectomy: analysis of 62 cases
- 陆军军医大学学报 2023年45卷第6期页码：561-569
- 作者机构：
  
  1.400038 重庆，陆军军医大学(第三军医大学)第一附属医院全军肝胆外科研究所
  2.400038 重庆，陆军军医大学(第三军医大学)第一附属医院神经外科
- 作者简介：
  
  [张雷达, E-mail: 2518569931@qq.com ZHANG Leida, E-mail: 2518569931@qq.com
- 基金信息：
  
  国家自然科学基金面上项目(81972760)
- DOI：10.16016/j.2097-0927.202206085
  中图分类号： R181.32;R730.56;R735.7
- 收稿：2022-06-14，
  
  修回：2023-02-20，
  
  纸质出版：2023-03-30
- 稿件说明：
移动端阅览
邓青松, 何明莲, 欧晏娇, 等. ALPPS一期术后未能行二期手术原因的临床分析[J]. 陆军军医大学学报, 2023,45(6):561-569.

Qingsong DENG, Minglian HE, Yanjiao OU, et al. Failure to perform second-stage operation after first one of associating liver partition and portal vein ligation for staged hepatectomy: analysis of 62 cases[J]. Journal of Army Medical University, 2023, 45(6): 561-569.
邓青松, 何明莲, 欧晏娇, 等. ALPPS一期术后未能行二期手术原因的临床分析[J]. 陆军军医大学学报, 2023,45(6):561-569. DOI： 10.16016/j.2097-0927.202206085.

Qingsong DENG, Minglian HE, Yanjiao OU, et al. Failure to perform second-stage operation after first one of associating liver partition and portal vein ligation for staged hepatectomy: analysis of 62 cases[J]. Journal of Army Medical University, 2023, 45(6): 561-569. DOI： 10.16016/j.2097-0927.202206085.

摘要

目的

总结联合肝脏分隔和门静脉结扎二步肝切除术(associating liver partition and portal vein ligation for staged hepatectomy

ALPPS)一期术后未能行二期手术的常见临床原因，进一步探讨影响二期手术进行的危险因素。

方法

采用横断面研究方法，收集2013年10月至2021年12月期间连续行ALPPS治疗的肝脏肿瘤患者的临床资料。其中男性54例，女性8例，年龄(49.1±10.4)岁。按是否成功行二期手术分为二期手术组和未行二期手术组。收集统计患者未行二期手术的临床原因，分析比较患者肿瘤直径、临床分期、Child-Pugh评分和肝脏分隔方式等基线特征、一期术前术后肝功能(转氨酶、胆红素和白蛋白水平)、术后并发症等临床资料。

结果

62例患者，有45例患者成功行二期手术，17例患者未行二期手术，其占比为27.4%。未行二期手术患者中开腹ALPPS组2例，射频辅助ALPPS(RALPPS)组11例，腹腔镜ALPPS组4例。在二期手术组和未行二期手术组患者中，肿瘤最大直径、门静脉癌栓形成差异具有统计学意义(

0.05)。肝功能方面，一期术前白蛋白、总胆红素和一期术后谷草转氨酶、总胆红素两组差异具有统计学意义(

0.05)。肺部炎症、胸水、腹水为常见一期术后并发症，其中一期术后腹水两组患者差异具有统计学意义(

0.05)，两组患者Ⅲ级及以上并发症发生率差异具有统计学意义(

0.001)。未行二期手术的患者的临床原因为肝脏未明显增生，未来残肝体积(future liver remnant volume，FLRV)不足，肝脏功能和储备功能差，并发症发生和肿瘤进展。多因素分析显示影响二期手术进行的危险因素为肿瘤最大直径、癌栓形成和一期术后并发症等级。

结论

对于肿瘤较大、门静脉癌栓形成肝癌患者选择ALPPS手术需慎重。

Abstract

Objective

To summarize the clinical reasons for failing to perform the second stage of operation after the first stage of operation of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS)

and to explore the risk factors affecting the second stage of operation.

Methods

A sectional-cross study was conducted on 62 patients (54 males and 8 females

age: 49.1±10.4) with liver tumors who were continuously treated with ALPPS from October 2013 to December 2021. The patients were divided into the second stage of operation group and the non-second-stage operation group according to whether they accepted the second stage of operation or not. The clinical reasons why patients were failing to have the second stage of operation were collected. The data of patients

including the tumor diameter

clinical stages

Child-Pugh score

liver separation mode

liver function (levels of transaminase

bilirubin and albumin) in the preoperative and postoperative of first stage operation period

and complications were analyzed.

Results

Among the 62 patients

45 patients successfully underwent the second stage of operation

and 17 patients failed to accept t

he second stage of operation

accounting for 27.4%. Among the patients who failed to accept the second stage of operation

there were 2 cases in the open ALPPS group

11 cases in the radiofrequency assisted ALPPS (RALPS) group

and 4 cases in the laparoscopic ALPPS group. The difference of maximum tumor diameter and the formation of portal vein tumor thrombus was statistically significant (

0.05). In terms of liver function

the differences in the level of albumin and total bilirubin tested before the first stage of operation and the level of aspartate aminotransferase and total bilirubin tested after the first stage of operation were statistically significant(

0.05). Pulmonary inflammation

pleural effusion and ascites were common complications of the first stage operation. There was significant difference between the 2 groups in complications of ascites of the first stage of operation(

0.05). There was significant difference in the incidence of complications(≥grade Ⅲ) between the 2 groups (

0.001). The clinical causes that patients failed to accepted the second stage of operation were no obvious liver hyperplasia

insufficient future liver remnant volume (FLRV)

poor liver function and hepatic reserve function

complications and progression of tumor. Multivariate analysis showed that the risk factors affecting the second stage of operation were the maximum tumor diameter

the formation of tumor thrombus and the grade of complications of the first stage operation.

Conclusion

ALPPS should be selected carefully for patients with large tumor and portal vein thrombosis.

关键词

Keywords

references

CLAVIEN P A, PETROWSKY H, DEOLIVEIRA M L, et al . Strategies for safer liver surgery and partial liver transplantati on[J ] . N Engl J Med, 2007, 356(15): 1545-1559. DOI: 10.1056/NEJMra065156.

KATAYAMA H, KUROKAWA Y, NAKAMURA K, et al . Extended Clavien-Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria[J ] . Surg Today, 2016, 46(6): 668-685. DOI: 10.1007/s00595-015-1236-x.

KAMBAKAMBA P, STOCKER D, REINER C S, et al . Liver kinetic growth rate predicts postoperative liver failure after ALPPS[J ] . HPB (Oxford), 2016, 18(10): 800-805. DOI: 10.1016/j.hpb.2016.07.005.

WANG Z, PENG Y F, HU J W, et al . Associating liver partition and portal vein ligation for staged hepatectomy for unresectable hepatitis B virus-related hepatocellular carcinoma: a single center study of 45 patients[J ] . Ann Surg, 2020, 271(3): 534-541. DOI: 10.1097/SLA.0000000000002942.

SCHADDE E, RAPTIS D A, SCHNITZBAUER A A, et al . Prediction of mortality after ALPPS stage-1: an analysis of 320 patients from the international ALPPS registry[J ] . Ann Surg, 2015, 262(5): 780-785;discussion 785-786. DOI: 10.1097/SLA.0000000000001450.

SCHADDE E, ARDILES V, ROBL ES-CAMPOS R, et al . Early survival and safety of ALPPS: first report of the International ALPPS Registry[J ] . Ann Surg, 2014, 260(5): 829-836;discussion 836-838. DOI: 10.1097/SLA.0000000000000947.

DENG Z F, JIN Z R, QIN Y H, et al . Efficacy of the association liver partition and portal vein ligation for staged hepatectomy for the treatment of solitary huge hepatocellular carcinoma: a retrospective single-center study[J ] . World J Surg Oncol, 2021, 19(1): 95. DOI: 10.1186/s12957-021-02199-1.

SCHADDE E, SCHNITZBAUER A A, TSCHUOR C, et al . Systematic review and meta-analysis of feasibility, safety, and efficacy of a novel procedure: associating liver partition and portal vein ligation for staged hepatectomy[J ] . Ann Surg Oncol, 2015, 22(9): 3109-3120. DOI: 10.1245/s10434-014-4213-5.

吴心强, 陈亚进. 肝硬化肝再生的研究进展[J]. 中华消化外科杂志, 2017, 16(2): 210-214. DOI: 10.3760/cma.j.issn.1673-9752.2017.02.019.

WU X Q, CHEN Y J. Research progress in liver regeneration of cirrhosis[J]. Chin J Dig Surg, 2017, 16(2): 210-214. DOI: 10.3760/cma.j.issn.1673-9752.2017.02.019.

林为东, 莫经刚. ALPPS促进剩余肝脏快速增生机制及相关因素研究进展[J]. 中国普通外科杂志, 2017, 26(8): 1065-1070. DOI: 10.3978/j.issn.1005-6947.2017.08.016.

LIN W D, MO J G. Mechanisms of ALPPS promoting rapid hypertrophy of future liver remnant and relevant factors: recentadvances[J]. Chin J Gen Surg, 2017, 26(8): 1065-1070. DOI: 10.3978/j.issn.1005-6947.2017.08.016.

金望迅, 王兵, 黄灵, 等. 影响二步肝切除术肝脏再生的主要因素研究[J]. 中华全科医学, 2019, 17(6): 927-931, 1032. DOI: 10.16766/j.cnki.issn.1674-4152.000827.

JIN W X, WANG B, HUANG L, et al . A retrospective study on the key factors that influence the liver regeneration after the stage-1 associating liver partition and portal ligation for staged hepatectomy[J ] . Chin J Gen Pract, 2019, 17(6): 927-931, 1032. DOI: 10.16766/j.cnki.issn.1674-4152.000827.

黄粲宸, 黄民, 肖乐, 等. ALPPS一期术后刺激残肝再生及其相关因素的研究[J]. 第三军医大学学报, 2018, 40(13): 1198-1204. DOI: 10.16016/j.1000-5404.201803122.

HUANG C C, HUANG M, XIAO L, et al . Liver regeneration and related factors after first step of ALPPS surgery in SD rats[J ] . J Third Mil Med Univ, 2018, 40(13): 1198-1204. DOI: 10.16016/j.1000-5404.201803122.

曹永, 揭彬, 郑树国, 等. 26例肝癌行ALPPS围手术期并发症的观察分析[J]. 第三军医大学学报, 2019, 41 (15): 1491-1496. DOI: 10.16016/j.1000-5404.201902155.

CAO Y, JIE B, ZHENG S G, et al . Clinical analysis of perioperative complications of 26 cases of liver cancer after ALPPS[J ] . J Third Mil Med Univ, 2019, 41(15): 1491-1496. DOI: 10.16016/j.1000-5404.201902155.

ZHANG J W, HUANG H C, BIAN J, et al . Safety, feasibility, and efficacy of associating liver partition and portal vein ligation for staged hepatectomy in treating hepatocellular carcinoma: a systematic review[J ] . Ann Transl Med, 2020, 8(19): 1246. DOI: 10.21037/atm-20-2214.

王强, 闫军, 冯晓彬, 等. 补救性射频消融或门静脉栓塞术联合射频辅助肝脏分隔和门静脉结扎的二步肝切除术治疗肝硬化肝癌[J]. 中华消化外科杂志, 2016, 15(5): 455-460. DOI: 10.3760/cma.j.issn.1673-9752.2016.05.011.

WANG Q, YAN J, FENG X B, et al . Remedial radiofrequency ablation or portal vein embolization combined with radiofrequency ablation-assistant associating liver partition and portal vein ligation for staged hepatectomy in the treatment of patients with hepatocellular carcinoma with cirrho[J ] . Chin J Dig Surg, 2016, 15(5): 455-460. DOI: 10.3760/cma.j.issn.1673-9752.2016.05.011.

ROZENBLUM N, ZEIRA E, BULVIK B, et al . Radio-frequency ablation: inflammatory changes in the periablative zone can induce global organ effects, including liver regeneration[J ] . Radiology, 2015, 276(2): 416-425. DOI: 10.1148/radiol.15141918.

ERINJERI J P, THOMAS C T, SAMOILIA A, et al . Image-guided thermal ablation of tumors increases the plasma level of interleukin-6 and interleukin-10[J ] . J Vasc Interv Radiol, 2013, 24(8): 1105-1112. DOI: 10.1016/j.jvir.2013.02.015.

ZHANG W K, ZHU X W, TANG Y, et al . Kupffer cells depletion alters cytokine expression and delays liver regeneration after Radio-frequency-assisted Liver Partition with Portal Vein Ligation[J ] . Mol Immunol, 2022, 144: 71-77. DOI: 10.1016/j.molimm.2022.02.016.

GALL T M, SODERGREN M H, FRAMPTON A E, et al . Radio-frequency-assisted Liver Partition with Portal vein ligation (RALPP) for liver regeneration[J ] . Ann Surg, 2015, 261(2): e45-e46. DOI: 10.1097/SLA.0000000000000607.

WANG Q, YAN J, FENG X B, et al . Safety and efficacy of radiofrequency-assisted ALPPS (RALPPS) in patients with cirrhosis-related hepatocellular carcinoma[J ] . Int J Hyperthermia, 2017, 33(7): 846-852. DOI: 10.1080/02656736.2017.1303752.

陈耿, 张琳, 周毅, 等. 联合同期超选择性肝动脉栓塞和门静脉栓塞的二步肝切除术治疗合并肝硬化的原发性肝癌[J]. 中华肝胆外科杂志, 2019, 25(4): 249-253. DOI: 10.3760/cma.j.issn.1007-8118.2019.04.003.

CHEN G, ZHANG L, ZHOU Y, et al . Simultaneous super-selective hepatic arterial and portal vein embolization for stagedhepatectomy in patients with hepatocellular carcinoma and cirrhosis[J ] . Chin J Hepatobil Surg, 2019, 2 5(4): 249-253. DOI: 10.3760/cma.j.issn.1007-8118.2019.04.003.

张远标, 洪德飞, 黄东胜, 等. 经皮微波或射频消融肝实质分隔联合门静脉栓塞计划性肝切除术治疗肝硬化肝癌[J]. 中华消化外科杂志, 2016, 15(5): 510-514. DOI: 10.3760/cma.j.issn.1673-9752.2016.05.020.

ZHANG Y B, HONG D F, HUANG D S, et al . Percutaneous microwave or radiofrequency ablation liver partition and portal vein embolization for planned hepatectomy[J ] . Chin J Dig Surg, 2016, 15(5): 510-514. DOI: 10.3760/cma.j.issn.1673-9752.2016.05.020.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

直肠癌术后回肠造口还纳患者发生低位前切除综合征的影响因素分析

肾移植受者运动恐惧潜在剖面分析及影响因素研究

经腹、经阴道超声介入穿刺硬化治疗卵巢巧克力囊肿术中疼痛影响因素分析

胰岛素低血糖激发试验出现不充分低血糖的影响因素研究